Ashraf M, Kobayashi H, Rahamathulla P M
Department of Pathology, University of Cincinnati Medical Center, OH 45267.
Am J Cardiovasc Pathol. 1989;2(4):351-64.
We have investigated the effect of ONO-3144 (2:aminomethyl-4-tert-butyl-propionylphenol), which accelerates the conversion of prostaglandin G2 to H2 and acts as a scavenger for free radicals, on the reoxygenation injury in the anoxic heart. Rat hearts were perfused retrogradely with Krebs-Henseleit (KH) medium for 30 minutes in Group I. In Group II, the hearts which were perfused with anoxic KH medium for 40 minutes were reoxygenated for 30 minutes. Group III was similar to Group II except that 4 mg ONO-3144/liter was added in anoxic medium. Group IV was similar to group III except ONO-3144 was present both during anoxia and reoxygenation. Coronary effluent was collected for the measurement of creatine phosphokinase (CPK). Tissue from each group was processed for electron microscopy, adenosine triphosphate (ATP), and tissue calcium. A six-fold increase in CPK leakage that was observed after reoxygenation of anoxic heart was prevented by ONO-3144. Tissue ATP was reduced from 21.65 +/- 1.1 mumol/gm dry weight (Group I) to 4.83 +/- 0.8 mumol/gm dry weight (Group II). A significant amount of ATP (9.05 +/- 1.22 mumol/gm dry weight) was preserved in the treated Group IV. The number of normal cells obtained by morphometrical analysis increased significantly from 24.2 +/- 8.4% (Group II) to 70.00 +/- 4.0% (Group IV), and severely injured cells were also reduced to 19.8 +/- 2.8% in the same group as compared to 54.8% in the untreated Group II. At the electron microscopic level, the cellular membranes, mitochondria, vascular endothelium, and glycogen deposits were well preserved in Group IV. The treatment during anoxia only did not minimize the reoxygenation damage (Group III). Thus, treatment with ONO-3144 provides a great protection against reoxygenation injury to the myocyte and vascular endothelium of the anoxic myocardium, perhaps by scavenging active oxygen species.
我们研究了ONO - 3144(2 - 氨甲基 - 4 - 叔丁基丙酰基苯酚)对缺氧心脏复氧损伤的影响。ONO - 3144可加速前列腺素G2向H2的转化,并作为自由基清除剂。在第一组中,大鼠心脏用Krebs - Henseleit(KH)培养基逆行灌注30分钟。在第二组中,用缺氧KH培养基灌注40分钟的心脏再进行30分钟的复氧。第三组与第二组相似,只是在缺氧培养基中添加了4mg/L的ONO - 3144。第四组与第三组相似,只是在缺氧和复氧过程中都存在ONO - 3144。收集冠状动脉流出液以测量肌酸磷酸激酶(CPK)。对每组组织进行电子显微镜检查、三磷酸腺苷(ATP)和组织钙的检测。缺氧心脏复氧后观察到的CPK泄漏增加了六倍,而ONO - 3144可防止这种情况。组织ATP从21.65±1.1μmol/g干重(第一组)降至4.83±0.8μmol/g干重(第二组)。在处理过的第四组中保留了大量的ATP(9.05±1.22μmol/g干重)。通过形态计量分析获得的正常细胞数量从24.2±8.4%(第二组)显著增加到70.00±4.0%(第四组),并且与未处理的第二组中54.8%相比,同一组中严重受损细胞也减少到19.8±2.8%。在电子显微镜水平上,第四组的细胞膜、线粒体、血管内皮和糖原沉积保存良好。仅在缺氧期间进行处理并不能使复氧损伤最小化(第三组)。因此,用ONO - 3144进行处理可为缺氧心肌的心肌细胞和血管内皮提供对复氧损伤的巨大保护,这可能是通过清除活性氧来实现的。